Reuters logo
10 months ago
BRIEF-Enanta Pharmaceuticals to present data on RSV inhibitor at annual RSV conference
September 29, 2016 / 8:36 PM / 10 months ago

BRIEF-Enanta Pharmaceuticals to present data on RSV inhibitor at annual RSV conference

1 Min Read

Sept 29 (Reuters) - Enanta Pharmaceuticals Inc:

* Presents data on a novel non-fusion inhibitor of Respiratory Syncytial Virus (RSV) at the 10th annual respiratory syncytial virus conference

* Further, EP-023938 maintained antiviral potency across all clinical isolates tested as well as virus that was resistant to fusion inhibitors

* Says lead compound shows promising anti-viral activity in rsv-A and rsv-B

* Says plans to continue evaluation of EP-023938 as a potential development candidate for RSV Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below